Oklahoma Heart Institute performed the first successful percutaneous transcatheter mitral valve repair procedure (MitraClip) in Tulsa November, 18, 2014. This procedure helps patients with mitral regurgitation who are too high-risk for surgery. Go inside the case at the hybrid lab.

Oklahoma Heart Institute performed the 55th Transcaval TAVR procedure in the world Tuesday, September 23, 2014. The TAVR team was led by Dr. Kamran Muhammad, Dr. Wayne Leimbach and Dr. Michael Phillips. 

“I thought this is serious,” says Andrea Eppley of the day she was admitted to the ICU at Oklahoma Heart Institute. She was pregnant with her second son and still five weeks before his due date. “I was really scared. What if I die?” Andrea had called her OB/Gyn Monday morning complaining of shortness of breath,…

For the 67 million Americans with high blood pressure, they may not feel any different when their blood pressure is elevated. Often referred to as the “silent killer” hypertension, or high blood pressure, usually has no warning signs or symptoms. That is why it is important to have regular physical exams with your primary care…

In 2013, Oklahoma Heart Institute joined institutions from around the world celebrating World Atrial Fibrillation (AFib) Awareness Day at our AFib and Yoga seminar and yoga session. It was a great success and this year we are happy to announce cardiac electrophysiologist Dr. David Sandler is taking the Oklahoma Heart Institute AFib and Yoga seminar to the…

Cardiologists and health care providers agree that there are things within our control and things outside of our control when it comes to reducing the risk of having a heart attack. These modifiable and non-modifiable risk factors give us our own individual risk for having a heart attack. While some of us may work really…

Don’t have time to exercise? It is understandably one of the biggest obstacles in our busy lifestyles to maintaining a regular exercise regime. However, what if carving our a mere five to ten minutes a day could give you additional years of life in return? Would you find the time? In the largest, most comprehensive study examining…

Gene Swepston is no stranger to Oklahoma Heart Institute. The marketing vendor who supplies various items such as the cough buddy, was admitted to the hospital in February of 2014. He shares his story and why he returned as soon as he was able to volunteer and help other patients. 

Oklahoma Heart Institute was the first in Oklahoma to use the Edwards Sapien XT valve for commercial use in a Transcatheter Aortic Valve Replacement (TAVR) procedure June 24, 2014. The team was lead by Drs. Kamran Muhammad, Paul Kempe, Wayne Leimbach, and Victor Cheng. Go inside the case to see how this valve will help more…